Universal Biosensors Inc. | Cash Flow

Fiscal year is January-December. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
11,633.80
9,316.10
6,576.40
1,250.30
764.70
37,564.40
Depreciation, Depletion & Amortization
2,497.30
2,512.90
2,697.20
2,646.20
2,589.50
2,113.50
Other Funds
814.90
288.40
1,107.40
1,128.50
467.00
2,642.20
Funds from Operations
8,321.60
6,514.70
2,771.90
2,768.00
2,291.70
42,320
Changes in Working Capital
8,307.00
1,100.90
2,244.00
4,280.70
6,398.00
40,555.60
Net Operating Cash Flow
16,628.60
5,413.90
527.80
7,048.70
8,689.70
1,764.40
Capital Expenditures
159.40
955.30
1,270.40
1,212.70
1,292.40
Sale of Fixed Assets & Businesses
-
7.90
-
-
-
Net Investing Cash Flow
159.40
947.40
1,270.40
1,272.20
1,021.10
Issuance/Reduction of Debt, Net
15,979.00
1,792.50
1,404.80
45.20
369.60
Net Financing Cash Flow
16,339.60
1,792.50
1,378.70
45.20
368.90
Net Change in Cash
93.00
7,412.60
1,979.50
6,052.00
5,857.60
Free Cash Flow
16,788.00
6,369.20
1,798.20
5,836.00
7,397.40
Net Assets from Acquisitions
-
-
-
59.50
-
Other Sources
-
-
-
-
271.30
Change in Capital Stock
360.60
-
26.10
-
0.80
Exchange Rate Effect
541.40
741.10
1,197.40
230.30
1,442.20

About Universal Biosensors

View Profile
Address
1 Corporate Avenue
Rowville Victoria (VIC) 3178
Australia
Employees -
Website http://www.universalbiosensors.com
Updated 07/08/2019
Universal Biosensors, Inc. engages in the research, development, and manufacture of medical diagnostics test systems for point-of-care professional and home use. Its products includes blood glucose monitoring, coagulation testing, immunoassay, and molecular diagnostics. The company was founded on September 14, 2001 and is headquartered in Rowville, Australia.